Get 40% Off
These stocks are up over 10% post earnings. Did you spot the buying opportunity? Our AI did.Read how

U.S. stocks are mixed after jobs report fails to calm rate fears

Published 07/07/2023, 15:16
© Reuters.

Investing.com -- U.S. stocks were mixed after Friday’s jobs report failed to calm fears about interest rates.

At 9:57 ET (13:57 GMT), the Dow Jones Industrial Average was down 23 points or less than 0.1%, while the S&P 500 was up 0.1% and the NASDAQ Composite was up 0.3%.

The June jobs report was weaker than expected, with 209,000 jobs added last month. Growth in average hourly earnings was unchanged at 0.4%, while the unemployment rate dipped to 3.6% from 3.7%.

Fed has incentive to raise rates

The numbers confirm that while job growth slowed the labor market remains tight, giving the Federal Reserve extra incentive to raise interest rates again at its next meeting this month. It is working to push inflation back to the 2% annual target, but a tight labor market and persistently high prices are keeping it on a more aggressive path.

Futures traders are factoring in a greater than 90% probability that the Fed will raise rates another quarter of a percentage point later this month and possibly again in the fall.

Indexes on track to end the week lower

That is putting pressure on megacap tech stocks, which soared in the first half of 2023 amid expectations that the Fed was nearing the end of its rate hiking.

All three major U.S. stock indexes were on track to end the week lower.

Treasury Secretary Janet Yellen is in China amid rising tensions between the U.S. and PRC over technology. Yellen said Beijing’s newly announced export controls on two strategic metals that are crucial to the global semiconductor industry were a “concern.”

3rd party Ad. Not an offer or recommendation by Investing.com. See disclosure here or remove ads .

Levi's shares fall after cutting outlook

Shares of Levi Strauss & Co Class A (NYSE:LEVI) were falling 6.7% after the denim apparel maker cut its forecast for the full year, below expectations and its previous guidance.

Biogen Inc (NASDAQ:BIIB) shares dipped 0.8% after news that the Food and Drug Administration has given full approval to its Leqembi, a drug to slow the progression of Alzheimer’s.

Oil was rising. Crude Oil WTI Futures were up 0.9% to $72.50 a barrel, while Brent Oil Futures were up 0.9% to $77.27 a barrel. Gold Futures were up 0.8% to $1,932.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.